T07-P-03 Evaluation of the quality of life and sexual functioning of women using oral hormonal contraceptive - Yasmin

Sexologies ◽  
2008 ◽  
Vol 17 ◽  
pp. S104
Author(s):  
V. Skrzypulec ◽  
A. Drosdzol
Keyword(s):  
Quality Of Life ◽  
Sexual Functioning ◽  
Hormonal Contraceptive

scholarly journals Effect of Hysterectomy vs Medical Treatment on Health-Related Quality of Life and Sexual Functioning

JAMA ◽  
2004 ◽  
Vol 291 (12) ◽  
pp. 1447 ◽  
Author(s):  
Miriam Kuppermann ◽  
R. Edward Varner ◽  
Robert L. Summitt, Jr ◽  
Lee A. Learman ◽  
Christine Ireland ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Medical Treatment ◽  
Sexual Functioning ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Quality of life of Zambian breast cancer women receiving care at the cancer diseases hospital Lusaka

2020 ◽  
Vol 10 (9) ◽  
pp. 57
Author(s):  
Masadza Wezzie ◽  
Siankulu Elaine ◽  
Kawalika Micheal ◽  
Victoria Mwiinga-Kalusopa ◽  
Patricia Katowa-Mukwato
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Sexual Functioning ◽  
Access To Health Care ◽  
Symptom Experience ◽  
Symptom Scale ◽  
Financial Status ◽  
Access To Health ◽  
Cancer Diseases

Background: Breast cancer is the most frequently diagnosed malignancy among women in the world with an estimation of 1.67 million new diagnoses worldwide in 2012 estimated at 25% of all cancers. In Zambia, breast cancer is the second most common cancer affecting women and accounts for 9% of all histologically proven cancers among patients admitted at the country’s only Cancer Diseases Hospital Most of the patients receive multiple treatment modalities; Surgery, Chemotherapy, Radiation Therapy and Hormonal Therapy, each with its own long-term side effects with a potential to affect  the women’s functionality, self-image and sexuality consequently the general quality of life of these women.Methods: A descriptive cross-sectional study design was used to investigate the Quality of Life (QoL) and factors influencing QoL among women with breast cancer receiving care at Zambia’s only Cancer Diseases Hospital. A total of 130 breast cancer patients on treatment who were willing to participate in the study were selected using simple random sampling. Data was collected using the European Organization for Research and Treatment in Cancer Quality of Life Questionnaire (EORTCQLQ–C30) and its breast cancer supplementary measure (QLQ-BR23). The tool assessed QoL across the physical, role, cognitive, emotional, and social functioning and sexual function domains.Results: Overall, just about half (52.5%) of the 130 respondents had high Quality of Life. QoL which was measured by the EORTCQLQ–C30 under the five domains (Physical, role, emotional, cognitive and sexual functioning) was high in four out of the five which scored above the global mean score of 68. Only the emotional functioning domain scored (65) below the mean. Conversely, the symptom scale scored high on all the eight sub items of fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation and diarrhea which signified high symptom experience among respondents. Similarly using the breast cancer supplementary measure (QLQ-BR23), two out of the four functional subscales (body image and sexual functioning) score high than average while sexual enjoyment and future perspectives score low. On the symptom scale, three out of the four scales scored higher than averages, signifying high symptom experience. Demographic characteristics which had significant association with QoL were age (p < .023), level of education (p < .023) and financial status (p < .000). Other factors that had significant association with QoL were type of treatment being received (p < .023), the severity of condition (p < .000), access to health care services (p < .000) and social support (p < .000).Conclusions: A diagnosis of breast cancer and its subsequent treatment affects several facets of a woman’s life ranging from physical, emotional, social and financial aspects consequently affecting the entire QoL. However the QoL varies and is influenced by a number of factors including age at diagnosis of cancer, level of education, financial status, type of treatment received, severity of the condition, access to health care facilities and social support. Therefore any intervention aimed at improving the QoL should be multidimensional.

Communicating about sexuality in cancer care

2017 ◽  
Author(s):  
John W. Robinson ◽  
Joshua J. Lounsberry ◽  
Lauren M. Walker
Keyword(s):  
Quality Of Life ◽  
Sexual Functioning ◽  
Cancer Care ◽  
Information Needs ◽  
Healthcare Professionals ◽  
Intervention Models ◽  
Life Issues ◽  
Sexual Concerns ◽  
Plissit Model

Extensive research has shown that cancer, and the treatment thereof, can interfere with healthy sexual functioning. Indeed, sexual dysfunction is frequently cited as one of the top adverse effects of cancer treatment. However, while healthcare professionals routinely discuss quality-of-life issues with cancer patients, the literature suggest that too often this does not include an assessment of sexual concerns. This chapter explains how the responsibility to initiate discussion on sexuality rests with the healthcare professional. Establishing the sexuality information needs of the cancer patient can sometimes be difficult and it becomes more so when healthcare professionals make erroneous assumptions concerning sexuality. Whether or not to assess sexuality is no longer a question, it must be a routine part of cancer care. While there are several different intervention models for patients suffering from sexual difficulties, the PLISSIT model is frequently used in cancer centres and easily adapted to various types of practice.

scholarly journals Quality of Life, Sexual Functioning, and Physical Functioning Following Perineal Reconstruction with the Lotus Petal Flap

2020 ◽  
Vol 27 (13) ◽  
pp. 5279-5285
Author(s):  
Joke Hellinga ◽  
Martin W. Stenekes ◽  
Paul M. N. Werker ◽  
Moniek Janse ◽  
Joke Fleer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Physical Examination ◽  
Physical Functioning ◽  
Sexual Functioning ◽  
Small Sample ◽  
Control Group ◽  
Hip Joints ◽  
Perineal Reconstruction ◽  
Perineal Herniation

Abstract Background Lotus petal flaps (LPF) may be used for the reconstruction of extralevator abdominoperineal defects that cannot be closed primarily. Limited data are available on how perineal reconstruction with the LPF impacts on patients’ quality of life (QoL), sexual functioning, and physical functioning. Methods A cross-sectional study was performed following perineal reconstruction with the LPF. The QoL of patients having undergone LPF reconstruction was compared with a control group in which perineal defects were closed without flaps. Sexual and physical functioning (presence of perineal herniation and range of motion [ROM] of the hip joints) could only be evaluated in the LPF group. Psychometrically sound questionnaires were used. Physical functioning was evaluated subjectively with binary questions and objectively by physical examination. Results Of the 23 patients asked to participate, 15 (65%) completed the questionnaires and 11 (47%) underwent physical examination. In the control group, 16 patients were included. There were no significant differences in QoL between the LPF and control groups. Within the LPF group, 33% of patients were sexually active postoperatively compared with 87% preoperatively. No perineal herniation was found. The ROM of the hip joints was bilaterally smaller compared with the generally accepted values. Conclusions Conclusions should be made with care given the small sample size. Despite a supposedly larger resection area in the LPF group, QoL was comparable in both groups. Nonetheless, reconstruction seemed to affect sexual function and physical function, not hampering overall satisfaction.

Quality of life and cognitive functioning impairment associated with cisplatin-based chemotherapy in testicular cancer survivors.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e21607-e21607 ◽  
Author(s):  
Michal Chovanec ◽  
Lucia Vasilkova ◽  
Lucia Setteyova ◽  
Katarina Rejlekova ◽  
Jana Obertova ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Testicular Cancer ◽  
Cognitive Functioning ◽  
Cognitive Abilities ◽  
Sexual Functioning ◽  
Subscale Score ◽  
Control Group ◽  
Eortc Qlq ◽  
The Impact

e21607 Background: Testicular cancer (GCT) survivors are at risk for different types of late treatment sequelae. This study aimed to evaluate long-term quality of life (QOL), sexual (SexF) and cognitive functioning (CogF) issues resulting from cisplatin-based chemotherapy. Methods: QoL, SexF and CogF data were prospectively collected in 83 GCT survivors with median 9 year follow-up (range 5-32). The chemotherapy group (CTG) consisted of 53 and 18 patients receiving a cisplatin cumulative dose of ≤ 400mg/m2 (LCD) and > 400mg/m2 (HCD), respectively. The control group (CG) included 12 patients treated with orchiectomy (6 pts) and adjuvant radiotherapy (6 pts). Data were collected using EORTC QLQ-C30, QLQ-TC26, FACT-Cog and sexual functioning questionnaires and analyzed according to the scoring guidelines. Results:The CTG survivors had significantly (all p < 0.05) more limitations while working or doing daily activities (37% vs 8%), needed to rest more often (61% vs 33%) and feared the disease relapse more often (73% vs 50%) compared to the CG. A subscale for family problems within QLQ-TC26 have shown higher impairment in the CTG vs. CG (mean score ± SEM: 54.2 ± 26.7 vs. 38.8. ± 7.3, P < 0.05). Cognitive abilities were perceived better in CG vs. CTG (mean score 24.5 ± 1.8 vs. 20.5 ± 0.7, P < 0.05). The CG surivors had higher education level and fathered more children compared to the CTG. The CTG felt more unsettled than the CG (all P < 0.05), however the impact of perceived cognitive impairment on their lives did not significantly differ ( P = 0.4). Patients who received HCD have suffered from dyspnea more often than patients treated with LCD (mean dyspnea subscale score ± SEM: 22.2 ± 4.4 vs 8.9 ± 2.6, P < 0.05). The HCD group also reported more difficulties to concentrate while watching television/reading newspaper and struggled to name things during conversation compared with the LCD group ( P < 0.05 for both). No impairment in sexual functioning was reported. Conclusions: Our study shows thatGCT survivors cured with cisplatin-based chemotherapy suffered from QoL issues and their perception of cognitive abilities was altered. The HCD of cisplatin further impaired several QoL and cognitive aspects.

Patient characteristics and correlation with sexual functioning and quality of life among female cancer survivors: Results of the WFU CCOP Research Base Protocol 97106.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e22094-e22094
Author(s):  
Nevine M. Hanna ◽  
Doug Case ◽  
Emily Van Meter Dressler ◽  
David Duane Hurd ◽  
Michelle Joy Naughton ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cancer Survivors ◽  
Sexual Functioning ◽  
Patient Characteristics ◽  
Female Cancer Survivors

scholarly journals Patient-Physician Communication About Health-Related Quality-of-Life Problems: Are Non-Hodgkin Lymphoma Survivors Willing to Talk?

2013 ◽  
Vol 31 (31) ◽  
pp. 3964-3970 ◽  
Author(s):  
Neeraj K. Arora ◽  
Roxanne E. Jensen ◽  
Nadiyah Sulayman ◽  
Ann S. Hamilton ◽  
Arnold L. Potosky
Keyword(s):  
Quality Of Life ◽  
Sexual Functioning ◽  
Daily Functioning ◽  
Health Related Quality ◽  
Non Hodgkin Lymphoma ◽  
Follow Up Care ◽  
Related Quality ◽  
Health Related

Purpose To investigate non-Hodgkin lymphoma (NHL) survivors' willingness to discuss health-related quality-of-life (HRQOL) problems with their follow-up care physician. Patients and Methods Willingness to discuss HRQOL problems (physical, daily, emotional, social, and sexual functioning) was examined among 374 NHL survivors, 2 to 5 years postdiagnosis. Survivors were asked if they would bring up HRQOL problems with their physician and indicate reasons why not. Logistic regression models examined the association of patient sociodemographics, clinical characteristics, follow-up care variables, and current HRQOL scores with willingness to discuss HRQOL problems. Results Overall, 94%, 82%, 76%, 43%, and 49% of survivors would initiate discussions of physical, daily, emotional, social, and sexual functioning, respectively. Survivors who indicated their physician “always” spent enough time with them or rated their care as “excellent” were more willing to discuss HRQOL problems (P < .05). Survivors reporting poorer physical health were less willing to discuss their daily functioning problems (P < .001). Men were more willing to discuss sexual problems than women (P < .001). One in three survivors cited “nothing can be done” as a reason for not discussing daily functioning problems, and at least one in four cited “this was not their doctor's job” and a preference to “talk to another clinician” as reasons for not discussing emotional, social, and sexual functioning. Conclusion NHL survivors' willingness to raise HRQOL problems with their physician varied by HRQOL domain. For some domains, even when survivors were experiencing problems, they may not discuss them. To deliver cancer care for the whole patient, interventions that facilitate survivor-clinician communication about survivors' HRQOL are needed.

Sign in / Sign up

Export Citation Format

Share Document